Dorizoe Lifesciences (earlier a separate legal entity 'Dorizoe Lifesciences Limited') is now a Business Unit of Altheon Enterprises Limited. Dorizoe Lifesciences (Dorizoe) is a full service global Contract Research & Development business, specialized in Sterile dosage forms, including parenteral and ophthalmic formulations. Our state-of-the-art R&D facility has classified lab and scale-up areas for handling general and high potent (Steroids, Cytotoxics) molecules. It has been audited successfully by most of the top companies in the USA and Europe as well as external auditors. We are also building capabilities in complex injectables/ophthalmics (Suspensions, Emulsions). We are open to support topical/oral liquid, oromucosal, nasal liquid spray, and inhalation delivery as per business case. We have a competent team of scientists across departments, including F&D, ADL, and QA. It works closely with API suppliers and CMOs globally to provide end-to-end product development and technology transfer solutions to pharmaceutical companies worldwide. Our expertise: A. Formulation Development 1. Parenteral • Small Volume Parenteral (Solutions) • Dry Powder Parenteral (Lyophilized Products, Dry Powder) • Large Volume Parenteral 2. Ophthalmic (Solutions) B. Analytical Development 1. Analytical Method Development • Gas Chromatography • HPLC • Ion Chromatography • Non-chromatographic Methods 2. Preformulation 3. Compatibility Studies 4. Impurity Profiling 5. Stability Studies 6. Analytical Method Validations C. Technology Transfer – 1. Large Volume Parenteral (LVP) 2. Small Volume Parenteral (SVP) Glass Vials • Oncology • Non Oncology • Lyophilized D. Project Management For exploring any strategic alliances or partnership opportunities, please visit http://www.dorizoe.com/Dorizoe-Lifesciences-Business-Opportunities.html